Consolidated Statements of Income - USD ($) shares in Millions, $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016	Jun. 30, 2015
Net Sales	$ 11,952	$ 12,910	$ 22,655	$ 25,280
Cost of sales	9,275	10,146	17,226	19,681
Research and development expenses	399	429	760	812
Selling, general and administrative expenses	787	773	1,529	1,525
Amortization of intangibles	122	109	225	211
Restructuring charges	454	375	452	375
Equity in earnings of nonconsolidated affiliates	82	272	121	440
Sundry income (expense) - net	2,550	385	1,309	1,048
Interest income	18	11	38	28
Interest expense and amortization of debt discount	208	232	409	473
Income Before Income Taxes	3,357	1,514	3,522	3,719
Provision for income taxes	130	317	20	1,003
Net Income	3,227	1,197	3,502	2,716
Net income (loss) attributable to noncontrolling interests	19	(23)	40	18
Net Income Attributable to The Dow Chemical Company	3,208	1,220	3,462	2,698
Preferred stock dividends	85	85	170	170
Net Income Available for The Dow Chemical Company Common Stockholders	$ 3,123	$ 1,135	$ 3,292	$ 2,528
Per Common Share Data:
Earnings per common share - basic	$ 2.79	$ 0.99	$ 2.96	$ 2.21
Earnings per common share - diluted	2.61	0.97	2.83	2.15
Dividends declared per share of common stock	$ 0.46	$ 0.42	$ 0.92	$ 0.84
Weighted-average common shares outstanding - basic	1,111.1	1,138.1	1,107.0	1,136.9
Weighted-average common shares outstanding - diluted	1,222.8	1,249.4	1,218.5	1,248.0
Depreciation	$ 511	$ 483	$ 967	$ 969
Capital Expenditures	$ 997	$ 998	$ 1,817	$ 1,901